Level Four Advisory Services’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
Other funds holding CYTK
PCH
RI
PHS
PAMS
Level Four Advisory Services's CYTK Position: Q4 2022 in Review
Level Four Advisory Services sold out of Cytokinetics (CYTK) in Q4 2022, closing a stake of 8,085 shares — an estimated $392K sold.
Level Four Advisory Services first reported a position in CYTK in Q1 2022 and held it in 3 quarters. The position peaked at $774K in Q2 2022. 277 funds tracked by Wall St. Rank hold CYTK as of Q4 2022.
- Level Four Advisory Services reported no remaining Cytokinetics position as of Q4 2022 after selling out during the quarter.
- Level Four Advisory Services sold 8,085 Cytokinetics shares in Q4 2022, an estimated $392K.
- Level Four Advisory Services first reported a position in Cytokinetics in Q1 2022 and held it in 3 quarters.
- Level Four Advisory Services's Cytokinetics position peaked at $774K in Q2 2022.
- 277 funds tracked by Wall St. Rank held Cytokinetics as of Q4 2022.
Based on Level Four Advisory Services's 13F filing for Q4 2022, filed 13 Feb 2023.